Our current knowledge of the efficacy of treating eating disorders
A) suggests that cognitive-behavioral therapy is the treatment of choice.
B) is much more detailed for anorexia nervosa than for bulimia nervosa.
C) is quite thorough because there are many controlled studies comparing long-term outcomes.
D) suggests that hospitalization is most effective for long-term maintenance of treatment gains.
Question 2
Drugs that alter the availability of norepinephrine and serotonin are not clinically effective in the treatment
of depression for several weeks. Which of the following does this finding suggest?
A) These neurotransmitters are not involved in depression.
B) That the effectiveness of antidepressants is a placebo effect, as opposed to a result of a biochemical
manipulation.
C) Changes in neurotransmitter function, as opposed to neurotransmitter level, cause depression.
D) It is overactivity of these neurotransmitters that underlies depression, not underactivity.
Selected Drugs for Psoriasis and Related Disorders
Current FDA Pregnancy Category Ratings with Examples
Fat-Soluble Vitamins for Treating Nutritional Disorders
Diagnostic Criteria for Eating Disorders
The Dose-Effect Relationship, Showing (A) Drug Potency and (B) Drug Efficacy (Or Effectiveness)
Testing Infants’ Knowledge